Imunon (IMNN) investor relations material

Executive summary

• Annual meeting scheduled for June 16, 2026, will be held virtually to enhance accessibility and reduce costs.

• Four key proposals: election of two Class I directors, ratification of auditor, advisory vote on executive compensation, and amendment to the 2018 Stock Incentive Plan.

• Record date for voting is April 17, 2026, with 3,983,342 shares outstanding.

• Proxy materials and annual report are available online and by request.

Voting matters and shareholder proposals

• Proposal 1: Elect two Class I Directors (Frederick J. Fritz and Christine A. Pellizzari) for terms expiring in 2029.

• Proposal 2: Ratify WithumSmith + Brown PC as independent auditor for fiscal year 2026.

• Proposal 3: Advisory vote to approve 2025 executive compensation.

• Proposal 4: Approve amendment to 2018 Stock Incentive Plan, increasing share limit by 1,000,000 shares.

• Shareholders may submit proposals for the 2027 annual meeting by specified deadlines.

Board of directors and corporate governance

• Board consists of six members divided into three staggered classes; four are independent.

• Committees include Audit, Compensation, Nominating and Governance, and Science and Technology.

• Board diversity: 2 female, 4 male directors; all are White.

• Annual review of board independence and director qualifications; stock ownership guidelines in place.